
|Articles|June 1, 2003
Lending A Helping Hand
San Francisco - A randomized, two-center study conducted at the University of Cincinnati and Oregon Health & Science University suggests that topical bexarotene gel (Targretin) 1 percent monotherapy may be a promising new treatment for severe chronic hand dermatitis.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















